Jasper Therapeutics
JSPR
JSPR
86 hedge funds and large institutions have $334M invested in Jasper Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 79 → 86 (+7)
7.18% more ownership
Funds ownership: 97.13% → 104.31% (+7.2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
86
Holding in Top 10
3
Calls
$6.82M
Puts
$2.76M
Top Buyers
| 1 | +$7.49M | |
| 2 | +$6.41M | |
| 3 | +$6.03M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$4.95M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.4M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.92M | |
| 3 | -$5.33M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.14M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$1.07M |